Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.
Pope B, Park G, Lau E, Belic J, Lach R, George A, McCoy P, Nguyen A, Grima C, Campbell B, Jung CH, Ditter EJ, Zhao H; Pan Prostate Cancer Group (PPCG); Wedge DC, Brewer DS, Lynch AG, Dev H, Gnanpragasam VJ, Rosenfeld N, Hovens CM, Corcoran NM, Massie CE.
Pope B, et al. Among authors: corcoran nm.
Eur Urol. 2024 Apr;85(4):407-410. doi: 10.1016/j.eururo.2024.01.002. Epub 2024 Feb 19.
Eur Urol. 2024.
PMID: 38378299
No abstract available.